InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
stocktrademan Free
12/18/15 3:55 PM

Santen Pharmaceutical Co. Ltd. (SNPHY) RSS Feed

Followers
0
Posters
1
Posts (Today)
0
Posts (Total)
1
Created
12/18/15
Type
Free
Moderators
Santen Pharmaceutical Co. Ltd. Grand Front Osaka Tower A 4-20 Ofuka-cho Osaka, 530-8552 Japan Phone: 81 6 6321 7000 Fax: 81 6 6321 5082 Website: http://www.santen.co.jp Santen Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and marketing of ophthalmic and anti-rheumatic pharmaceuticals for the protection and enhancement of eyesight and health. The company offers various prescription pharmaceuticals in the areas, such as corneal and conjunctival epithelial disorders; glaucoma and ocular hypertension; retinal and uveal disorders; ocular infections/allergy; and rheumatoid arthritis. It also provides over-the-counter pharmaceuticals; and medical devices, such as foldable intraocular lenses. In addition, the company involved in cleaning antidust and sterilized clothing; and selling supplements, as well as marketing support for pharmaceuticals. Santen Pharmaceutical Co., Ltd. offers its products in Japan, rest of Asia, Europe, North America, and internationally. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
SNPHY Latest News
  • No Recent News Available for this company!
New Post